Pharma Lab CRO ApS: Financial statements 2024
CVR: 40729364
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Lab CRO ApS (CVR 40729364) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,393,130 and a net result of DKK 117,249 compared with DKK -2,114,659 the year before. Equity in the 2024 report amounted to DKK -5,012,460. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,393,130
- Profit/Loss
- DKK 117,249
- Equity
- DKK -5,012,460
- Total Assets
- DKK 13,706,656
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.4M | 117K | -5M | 2 |
| 2023 | - | -2.1M | -2.1M | 142K | 2 |
| 2022 | - | 1.6M | 43K | 2.3M | 2 |
| 2021 | - | 2.4M | 1.8M | 2.2M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Lab CRO ApS has published its annual report for 2023. Gross profit came to DKK -2,086,073, and the net result was DKK -2,114,659.
As of June 24, 2024, JaJR Holding 2 ApS is registered as an owner of Pharma Lab CRO ApS with an ownership share of 100%.
About Pharma Lab CRO ApS
Pharma Lab CRO ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Juul Rasmussen. The company is owned by JaJR Holding 2 ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,665,168 and a net result of DKK -299,305 compared with DKK 117,249 the year before. Equity in the 2025 report amounted to DKK -5,311,766.